[1] |
BRACE R A,WOLF E J.Normal amniotic fluid volume changes throughout pregnancy[J].Am J Obstet Gynecol,1989,161(2):382-388.
|
[2] |
KAVIANI A,PERRY T E,DZAKOVIC A,et al.The amniotic fluid as a source of cells for fetal tissue engineering[J].J Pediatr Surg,2001,36(11):1662-1665.
|
[3] |
PHERMTHAI T,ODGLUN Y,JULAVIJITPHONG S,et al.A novel method to derive amniotic fluid stem cells for therapeutic purposes[J].BMC Cell Biol,2010,11(1):79.
|
[4] |
KANG N H,HWANG K A,KIM S U,et al.Potential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid-derived stem cells[J].Cancer Gene Ther,2012,19(8):517-522.
|
[5] |
KIM E Y,LEE K B,KIM M K.The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy[J].BMB Rep,2014,47(3):135-140.
|
[6] |
LI B,LEE C,CHUSLIP S,et al.Intestinal epithelial tight junctions and permeability can be rescued through the regulation of endoplasmic reticulum stress by amniotic fluid stem cells during necrotizing enterocolitis[J].FASEB J,2021,35(1):e21265.
|
[7] |
OCHIAI D,ABE Y,FUKUTAKE M,et al.Cell sheets using human amniotic fluid stem cells reduce tissue fibrosis in murine full-thickness skin wounds[J].Tissue Cell,2021,68:101472.
|
[8] |
FANG Y H,WANG S P H,CHANG H Y,et al.Progress and challenges of amniotic fluid derived stem cells in therapy of ischemic heart disease[J].Int J Mol Sci,2020,22(1):102.
|
[9] |
MOREAU R,RAUTOU P E.G-CSF therapy for severe alcoholic hepatitis:targeting liver regeneration or neutrophil function?[J].Am J Gastroenterol,2014,109(9):1424-1426.
|
[10] |
SINGH V,SHARMA A K,NARASIMHAN R L,et al.Granulocyte colony-stimulating factor in severe alcoholic hepatitis:a randomized pilot study[J].Am J Gastroenterol,2014,109(9):1417-1423.
|
[11] |
SUK K T,YOON J H,KIM M Y,et al.Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis:Phase 2 trial[J].Hepatology,2016,64(6):2185-2197.
|
[12] |
LI J,XING F Y,CHEN F,et al.Functional 3D human liver bud assembled from MSC-Derived multiple liver cell lineages[J].Cell Transplant,2019,28(5):510-521.
|
[13] |
PENG S Y,CHOU C J,CHENG P J,et al.Therapeutic potential of amniotic-fluid-derived stem cells on liver fibrosis model in mice[J].Taiwan J Obstet Gynecol,2014,53(2):151-157.
|
[14] |
中华医学会,中华医学会杂志社,中华医学会消化病学分会.酒精性肝病基层诊疗指南(2019年)[J].临床肝胆病杂志,2021,37(1):36-40.Chinese Medical Association,Chinese Medical Journals Publishing House,Chinese Society of Gastroenterology,Chinese Medical Association.Guideline for primary care of alcoholic liver disease:practice version (2019)[J].Journal of Clinical Hepatology,2021,37(1):36-40.(in Chinese)
|
[15] |
GAO Y H,ZHU Z Q,ZHAO Y H,et al.Multilineage potential research of bovine amniotic fluid mesenchymal stem cells[J].Int J Mol Sci,2014,15(3):3698-3710.
|
[16] |
NAGANO M,BRINSTER C J,ORWIG K E,et al.Transgenic mice produced by retroviral transduction of male germ-line stem cells[J].Proc Natl Acad Sci U S A,2001,98(23):13090-13095.
|
[17] |
NAGANO M,WATSON D J,RYU B Y,et al.Lentiviral vector transduction of male germ line stem cells in mice[J].FEBS Lett,2002,524(1-3):111-115.
|
[18] |
PRUSA A R,HENGSTSCHLAGER M.Amniotic fluid cells and human stem cell research:a new connection[J].Med Sci Monit,2002,8(11):RA253-RA257.
|
[19] |
ROUBELAKIS M G,TROHATOU O,ANAGNOU N P.Amniotic fluid and amniotic membrane stem cells:marker discovery[J].Stem Cells Int,2012,2012:107836.
|
[20] |
FAUZA D.Amniotic fluid and placental stem cells[J].Best Pract Res Clin Obstet Gynaecol,2004,18(6):877-891.
|
[21] |
赵天,李谷月,潘阳阳,等.Oct 4在牦牛卵母细胞及早期胚胎发育过程中的表达[J].畜牧兽医学报,2017,48(3):577-584.ZHAO T,LI G Y,PAN Y Y,et al.The expression of octamer-binding transcription factor 4 gene (Oct 4) in yak (Bos grunneins) oocytes and preimplantation embryos produced by in vitro fertilization[J].Acta Veterinaria et Zootechnica Sinica,2017,48(3):577-584. (in Chinese)
|
[22] |
ZHU H,JIA Z Q,MISRA H,et al.Oxidative stress and redox signaling mechanisms of alcoholic liver disease:Updated experimental and clinical evidence[J].J Dig Dis,2012,13(3):133-142.
|
[23] |
HARTMANN P,SEEBAUER C T,SCHNABL B.Alcoholic liver disease:the gut microbiome and liver cross talk[J].Alcohol Clin Exp Res,2015,39(5):763-775.
|
[24] |
WAN J H,BENKDANE M,TEIXEIRA-CLERC F,et al.M2 Kupffer cells promote M1 Kupffer cell apoptosis:a protective mechanism against alcoholic and nonalcoholic fatty liver disease[J].Hepatology,2014,59(1):130-142.
|
[25] |
SHAO T,ZHAO C Q,LI F Y,et al.Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction[J].J Hepatol,2018,69(4):886-895.
|
[26] |
NATH B,LEVIN I,CSAK T,et al.Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice[J].Hepatology,2011,53(5):1526-1537.
|
[27] |
ZHANG C W,ELLIS J L,YIN C Y.Inhibition of vascular endothelial growth factor signaling facilitates liver repair from acute ethanol-induced injury in zebrafish[J].Dis Model Mech,2016,9(11):1383-1396.
|
[28] |
JIA L,CHANG X L,QIAN S W,et al.Hepatocyte toll-like receptor 4 deficiency protects against alcohol-induced fatty liver disease[J].Mol Metab,2018,14:121-129.
|